Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (2) , 281-289
- https://doi.org/10.1016/s0168-8278(98)80014-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Distinct Patterns of Cyclin D1 Regulation in Models of Liver Regeneration and Human LiverBiochemical and Biophysical Research Communications, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinomaHepatology, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Amplification and Overexpression of Cyclin D1 in Human Hepatocellular CarcinomaBiochemical and Biophysical Research Communications, 1993
- Expression and Hypomethylation of α-Fetoprotein Gene in Unicentric and Multicentric Human Hepatocellular CarcinomasHepatology, 1993
- Tumor invasiveness and prognosis in resected hepatocellular carcinoma.Clinical and pathogenetic implicationsCancer, 1988
- Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCCCancer, 1985